PANI, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 156.530
NA - Nord America 10.891
AS - Asia 4.428
SA - Sud America 580
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 94
OC - Oceania 6
Totale 172.685
Nazione #
IT - Italia 151.751
US - Stati Uniti d'America 10.708
NL - Olanda 1.897
CN - Cina 1.764
SG - Singapore 1.590
UA - Ucraina 827
SE - Svezia 579
BR - Brasile 446
DE - Germania 398
VN - Vietnam 329
FI - Finlandia 315
GB - Regno Unito 310
FR - Francia 233
HK - Hong Kong 181
IN - India 124
KR - Corea 100
CA - Canada 99
BD - Bangladesh 83
AR - Argentina 51
RU - Federazione Russa 51
IQ - Iraq 33
PL - Polonia 33
JP - Giappone 28
MX - Messico 26
EC - Ecuador 25
TR - Turchia 24
ES - Italia 23
PK - Pakistan 23
BE - Belgio 22
ID - Indonesia 21
ZA - Sudafrica 20
CO - Colombia 18
MA - Marocco 18
IE - Irlanda 17
PH - Filippine 16
SA - Arabia Saudita 16
VE - Venezuela 16
MY - Malesia 13
IL - Israele 12
UZ - Uzbekistan 11
MU - Mauritius 10
AT - Austria 9
CR - Costa Rica 9
CZ - Repubblica Ceca 9
LT - Lituania 9
GT - Guatemala 8
JO - Giordania 8
DZ - Algeria 7
JM - Giamaica 7
KE - Kenya 7
PY - Paraguay 7
SC - Seychelles 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 6
HU - Ungheria 6
LB - Libano 6
RO - Romania 6
CH - Svizzera 5
EG - Egitto 5
EU - Europa 5
NI - Nicaragua 5
NP - Nepal 5
PE - Perù 5
SV - El Salvador 5
AZ - Azerbaigian 4
DK - Danimarca 4
HN - Honduras 4
IR - Iran 4
NG - Nigeria 4
PR - Porto Rico 4
TN - Tunisia 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GR - Grecia 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LY - Libia 2
MM - Myanmar 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
Totale 172.515
Città #
Cagliari 148.882
Uta 2.292
Amsterdam 1.876
Ashburn 1.380
Singapore 861
Woodbridge 736
Fairfield 733
Chandler 706
San Jose 683
Houston 557
Boardman 474
Jacksonville 453
Ann Arbor 434
Dallas 388
Wilmington 379
Beijing 337
Nyköping 336
Seattle 292
Cambridge 248
Dearborn 207
Helsinki 182
Hefei 180
Hong Kong 159
Los Angeles 159
Santa Clara 158
Nanjing 147
Council Bluffs 124
Lauterbourg 124
Shanghai 119
New York 113
Boston 100
Ho Chi Minh City 100
Seoul 93
Buffalo 90
Milan 80
Hanoi 75
The Dalles 70
São Paulo 65
Shenyang 63
Nanchang 58
Guangzhou 53
Rome 46
Columbus 44
Toronto 41
Hebei 40
Jiaxing 39
Redwood City 38
San Diego 38
Verona 36
Orem 33
Brooklyn 32
Chicago 29
Jinan 29
Changsha 28
Dong Ket 28
Mountain View 27
Falls Church 25
Tianjin 25
Warsaw 25
Atlanta 24
San Francisco 23
Munich 22
Tokyo 22
Phoenix 21
Brussels 20
Norwalk 20
Pune 20
Redondo Beach 20
Washington 20
Zhengzhou 19
Frankfurt am Main 18
London 17
North Bergen 17
Chennai 16
Montreal 16
Da Nang 15
Palermo 15
Dublin 14
Manchester 14
Rio de Janeiro 14
Auburn Hills 13
Haiphong 13
Stockholm 13
Baghdad 12
Denver 12
Mumbai 12
Orange 12
Princeton 12
Hangzhou 11
Kunming 11
Ningbo 11
Curitiba 10
Newark 10
Philadelphia 10
Sassari 10
Taizhou 10
Charlotte 9
Mexico City 9
Quito 9
Wuhan 9
Totale 165.774
Nome #
Mixed thiophene-phenanthroline Cu(II) complexes: synthesis, equilibria and cytotoxicity 4.874
Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study 4.370
Mixed thiophene-phenanthroline Cu (II) complexes: synthesis, antiviral and antiproliferative activity 4.272
1H NMR brain metabonomics of scrapie exposed sheep 4.072
Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4) 3.991
Novel coumarins and related copper complexes with biological activity: DNA binding, molecular docking and in vitro antiproliferative activity 3.693
Lipid profiles in brains from sheep with natural scrapie 3.496
Mixed-1,10-phenanthroline-Cu(II) complexes: Synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione 3.345
Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks 3.281
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC 3.226
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.218
New Ruthenium (III) complexes with antitumor activity: design, synthesis and characterization 3.186
Platinum complexes with 1,10-phenanthroline derivatives: synthesis, kinetics and in vitro cytotoxicity. 3.122
null 3.087
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 3.049
Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells 3.041
Synergistic effects of copper(II) complexes and cisplatin: an application of artificial neural networks and experimental design 2.934
Synergistic cytotoxicity of copper(II) complexes in combination with cisplatin: an application of artificial neural networks and experimental design 2.843
Cisplatin, glutathione and the third wheel: a copper-(1,10-phenthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin 2.697
Biochemical and molecular modifications in sheep brains during natural scrapie. 2.651
RT-QuIC detection of PrPsCJD spiked into human urine 2.636
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.619
Drug Discovery: towards the identification and characterization of new lead compounds as anticancer and antiprion agents 2.571
Drug Discovery: towards the identification and characterization of new lead compounds for the design of new anticancer and antiprion agents 2.523
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.513
Altered cholesterol ester cycle in ex vivo skin fibroblasts from Alzheimer patients 2.461
Biochemical and molecular modifications in sheep brains during natural scrapie 2.452
Influence of hydrocortisone on cytopathic effect of Newcastle disease virus and stability to freezing of vescicular stomatitis virus 2.415
Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains 2.339
Cholesterol homeostasis and prion misfolding: a comparative study in mouse neuroblastoma cells and in sheep brains and skin fibroblasts 2.309
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.307
Altered proteolysis in fibroblasts of alzheimer patients with predictive implications for subjects at risk of disease 2.268
Intra and intercellular distribution pf mitochondrial probes: a comparison between TMRM and JC-1 2.256
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.154
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays 2.136
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. XII Congresso Federazione Italiana Scienze della Vita (FISV). Universita` La Sapienza Roma (Italia), 24-27 Settembre 2012. 2.115
Studies on role of cholesterol in the pathogenesis of prion disorders 2.105
null 1.934
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.914
null 1.848
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.825
Ultrasensitive detection of prion seeding activity by RT-QuIC and eQuIC assays for early diagnosis of prion diseases 1.725
Cholesterol Metabolism in Brain and Skin Fibroblasts from Sarda Breed Sheep With Scrapie-resistant and Scrapie-susceptible Genotypes 1.689
null 1.664
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.239
ACAT1, Cav-1, and PrP expression in brains and skin fibroblasts from Sarda breed sheep with scrapie-resistant and scrapie-susceptible genotype 1.235
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 1.228
Neurodegenerative diseases and protein misfolding: novel targets and new inhibitors 1.173
1 ß ribofuranosyl pyrazolo derivati e relativo processo di produzione e impiego farmacologico 1.166
null 1.142
null 1.133
Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126. 1.099
MDR1 cholesterol esterification and cell growth. A comparative study in normal and multidrug resistant KB cell lines 1.004
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition 977
Changes in cholesterol metabolism in peripheral cells of Alzheimer disease patients and their relatives 976
Possibile nuovo biomarker diagnostico di malattia di Alzheimer: gli esteri del colesterolo 967
Derivatives of the new ring system indolo (1,2-c) benzo (1,2,3) triazine with potent antitumor and antimicrobial activity 858
Intra- and intercellular distribution of mitochondrial probes and changes after treatment with MDR modulators 823
Synthesis, solution equilibria and cytotoxic activity of new copper(II) complexes with 1,10-phenanthroline derivatives 805
Correlation between cholesterol esterification MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines 772
Cholesterol metabolism in brain and skin fibroblasts from Sarda breed sheep with scrapie resistant or susceptible genotype 745
Protein misfolding diseases: novel targets and new inhibitors 709
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 705
Synthesis, structural characterisation, complex formation constants and in vitro cytotoxicity of some copper(II) complexes 699
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 644
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 639
Pyrazole related nucleosides. Synthesis and antiviral / antitumor activity of some substituted pyrazole and pyrazolo [4,3-d]1,2,3-triazin-4-one nucleosides 628
Nuovi composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus 622
Antiviral activity of glycyrrhizic acid 596
Glycyrrhizic acid inhibits virus growth and inactivates virus particles 581
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells 580
Anti-prion activity of cholesterol esterification modulators: a comparative study in ex vivo sheep fibroblasts and lymphocytes and in mouse neuroblastoma cell lines 565
Translational control in L-cells infected by Vesicular Stomatitis Virus or Mengovirus 554
Prpspettive in tema di antivirali 546
Pyrazole-related nucleosides. Design, synthesis and antiproliferative activity of methyl 4-iodo-1--D -ribofuranosyl-pyrazole-3-carboxylate (IPCAR) and derivatives, against human leukemia, lymphoma and solid tumor cell lines in vitro 539
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 535
Inactivation by freezing of vesicular stomatitis virus treated with hydrocortisone 509
On the inhibitory effect of 2-amino-4,6-pyrimidines. 504
Oligodeossinucleotidi nativi selettivamente attivi in vitro contro il virus dell'immunodeficienza umana di tipo 1: ruolo del G-quartet. 503
Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines 474
Variation in resistance of cells from inbred strains of mice to herpes simplex virus type 1 469
Synthesis, biological evaluation and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitro imidazoles targeted at the HIV-1 reverse transcriptase 460
Synthesis of new disoxaril analogues with potent and selective anti-HRV-14 activity 455
Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients 454
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from polio infected cells 450
Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artefactual production of procapsids 442
A Kinase able to phosphorylate exogenous protein synthesis initiation factor eIF 2a is present in lysates of mengovirus infected L cells 442
Perspectives in antiviral chemotherapy 437
Prophylactic and/or therapeutic treatment of proliferative and conformational diseases 428
HIV-1 integrase inhibitors that block HIV-1 replication in infected cells: planning synthetic derivatives from natural products 425
On the antiviral action of glycyrrhized acid. II. Non involvement of cell membrane transport of ions and metabolites in the antiviral effect 421
Neutral Lipid Determination in Peripheral Blood Mononuclear Cells: A Useful Tool for Diagnostic and Therapeutic Interventions in Dementia 417
CELL GROWTH AND CHOLESTEROL ESTERS 414
Antiherpes activity of 5 (2 bromoethyl)2' deoxyuridine 397
Models for viral resistance or dependence 386
Design, Synthesis, SAR, and Molecular Modeling Studies of Acylthiocarbamates: A Novel Series of Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Structurally Related to Phenethylthiazolylthiourea Derivatives 382
Pyocianine-induced DNA breakage and repair 381
Methods for diagnosis and treatment of proliferative and conformational diseases 376
null 374
Synthesis and evaluation of anti HIV 1 and antitumor activity of 2',3' didehydro 2', 3' dideoxy 3 deazaadenosine, 2',3' dideoxy 3 deazaadenosine and some 2',3' dideoxy 3 deaza adenosine 5' dialkylphosphates 371
Totale 158.081
Categoria #
all - tutte 228.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 228.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.506 0 0 0 0 895 617 578 349 473 779 843 972
2022/202310.222 949 1.074 1.166 912 978 1.206 433 817 733 637 823 494
2023/202411.274 573 498 530 827 1.073 1.557 1.708 818 565 833 1.250 1.042
2024/202517.322 2.468 5.066 2.680 1.885 1.278 1.269 1.498 150 283 161 242 342
2025/20268.857 423 441 847 624 583 511 1.157 340 2.337 746 474 374
2026/20272.004 130 312 678 778 106 0 0 0 0 0 0 0
Totale 172.685